Extrait

Background and study aims We have developed and tested a new, responsive method which enables people with psychosis to monitor their symptoms. This led to the development of a smartphone application, known as ClinTouch, which collects and uploads symptom information securely to a central computer server several times daily. Who can participate? Adults who have been diagnosed with schizophrenia or other related mental disorders can take part. What does the study involve? Participants will be randomly allocated either to use the ClinTouch app for 12 weeks or to not use the app. The app beeps four times daily to prompt the user to respond to a simple set of symptom questions. This information is made available to a user's mental health team who can use it to tailor the support they provide (CareLoop). The computer server checks if the user is becoming unwell or if they are at increased risk of harming themselves and alerts the health team. Users may also personalise the look of the app and the way certain features work, as well as complete an accompanying personal daily diary. All participants will be followed up. What are the possible benefits and risks of participating? Participants who take part may benefit from using a new system which helps them to keep track of their mood and symptoms, and communicate these experiences with their mental health team. Where is the study run from? This study is being run by the University of Manchester and the Institute of Psychiatry at King's College, London, with the help of Manchester Mental Health and Social Care, and South London and Maudsley Trusts. When is the study starting and how long is it expected to run for? The study will start in May 2014 and lasts for one year. Who is funding the study? Medical Research Council (MRC) (UK). Who is the main contact? Dr Eve Applegate [email protected]

Critère d'inclusion

• Topic: Mental Health; Subtopic: Schizophrenia; Disease: Schizophrenia

Liens

• ictrp
• isrctn